Search research articles
Contact Us
Filters
Showing results (421-430 of 445) with videos related to
Page
of 45
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma
Letizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
Endocrine-Related Cancer
|
March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
Katharina Wang, Ina Schütze, Sebastian Gulde, et al.
European Journal of Endocrinology
|
February 2, 2023
International multicenter survey on screening and confirmatory testing in primary aldosteronism
Mitsuhide Naruse, Masanori Murakami, Takuyuki Katabami, et al.
Metabolism: Clinical and Experimental
|
June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors
Sudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer
Anne Jouinot, Guillaume Assie, Rossella Libe, et al.
The Lancet. Diabetes & Endocrinology
|
August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Massimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Cancers
|
October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
María Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis
Vasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
The Lancet. Diabetes & Endocrinology
|
October 7, 2021
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, et al.
Page
of 45
Search research articles
Search
Showing results (421-430 of 445) with videos related to
Sort By:
Page
of 45
The Journal of Clinical Endocrinology and Metabolism
|
November 2, 2018
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma
Letizia Canu, Janna A W Van Hemert, Michiel N Kerstens, et al.
Endocrine-Related Cancer
|
March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
Katharina Wang, Ina Schütze, Sebastian Gulde, et al.
European Journal of Endocrinology
|
February 2, 2023
International multicenter survey on screening and confirmatory testing in primary aldosteronism
Mitsuhide Naruse, Masanori Murakami, Takuyuki Katabami, et al.
Metabolism: Clinical and Experimental
|
June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors
Sudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer
Anne Jouinot, Guillaume Assie, Rossella Libe, et al.
The Lancet. Diabetes & Endocrinology
|
August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Massimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Cancers
|
October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
María Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis
Vasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
The Lancet. Diabetes & Endocrinology
|
October 7, 2021
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, et al.
Page
of 45